Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Cash Flows (Unaudited)

v3.20.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Aug. 31, 2019
Aug. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss $ (1,306,361) $ (556,903) $ (2,172,176) $ (2,343,491)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock based compensation 168,019 41,051 425,110 290,004
Depreciation 124 70 510 290
Change in fair value for the period of warrant derivative liability (29,501)   (1,006,099)  
Stock payable     100,000  
Changes in operating assets and liabilities:        
Prepaid expenses (77,797) (9,462) 27,048 (35,384)
Other receivable (36,800) 18,665 13,340 (22,127)
Accounts payable and accrued liabilities 230,667 105,427 (180,409) 500,696
Net cash used in operating activities (1,051,649) (401,152) (2,792,676) (1,610,020)
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchase of equipment     (688) (845)
Purchase of license     (1,500,000)  
Net cash used in investing activities     (1,500,688) (845)
CASH FLOWS FROM FINANCING ACTIVITIES        
Issuance of common shares for cash   170,774 8,376,379 1,386,613
Common stock issuance costs (15,151)      
Refund for fractional stock (117)      
Advance from related parties 4,334 3,686 18,276 19,894
Repayments to related parties (3,040) (558) (17,228) (18,056)
Net cash provided by financing activities (13,974) 173,902 8,377,427 1,388,451
Effects on changes in foreign exchange rate 16,341 4,900 2,478 (12,937)
Net decrease in cash and cash equivalents (1,049,282) (222,350) 4,086,541 (235,351)
Cash and cash equivalents - beginning of period 4,423,965 337,424 337,424 572,775
Cash and cash equivalents - end of period 3,374,683   4,423,965 337,424
Supplemental Cash Flow        
Cash paid for interest 0 0 0 0
Cash paid for income taxes 0 $ 0 0 $ 0
Non-cash financing and investing activities:        
Common shares issued for acquisition of license offset against stock payable 539,417      
Common shares issued for settlement of stock payable $ 100,000      
Reclass of warrant derivative liability from equity     1,035,600  
Share issuance for price protection     $ 13